You have 9 free searches left this month | for more free features.

City

Overall Status

Not yet recruiting (2)

Available (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Institut de Recherches Internationales Servier (2)

Servier (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Servier Pharmaceuticals, LLC (1)

Intervention

vorasidenib (3)

pembrolizumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Expanded Access (1)

vorasidenib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatic Impairment Trial (Vorasidenib)

Not yet recruiting

Hepatic Impairment

Vorasidenib

(no location specified)

Dec 30, 2022

Astrocytoma Trial (Vorasidenib, Pembrolizumab)

Not yet recruiting

Astrocytoma

Vorasidenib
Pembrolizumab

(no location specified)

Aug 1, 2022

Glioma, Recurrence, Disease Attributes Trial (Vorasidenib)

Available

Glioma
+10 more

Vorasidenib

(no location specified)

Oct 19, 2022